semaglutide and optic neuritis A recent Veterans Health Administration–based target trial emulation evaluated the incidence of nonarteritic anterior ischemic neuropathy (NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 Once-weekly semaglutide doubles the five-year

Lets break that down

Effects of treatment discontinuation Interestingly, the positive effects of SFN treatment appeared to regress after discontinuation

Available online at: (Accessed May 9, 2025)

Corticosterone as a marker of susceptibility to oxidative/nitrosative cerebral damage after stress exposure in rats

For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors Access this article Similar content being viewed by others Data Availability The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request